Live Analyst Rating Changes 25350 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Farrell Granath
BofA

Farrell Granath

Bank of America Securities
Wall Street Analyst
★★★☆☆
#1821
on 13Foresight · ranked by our own returns
43%
Success Rate
+2.6%
Average Return
12 of 28 calls profitable · +53.0% vs benchmark
S&P 500 (SPY)
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 43% of Farrell Granath's ratings turned a profit when each position was held for 1 year — averaging +2.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

47 Buy 10 Hold 5 Sell
Farrell's Stock Coverage 10 ratings · 2026-08-18
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
AHR
American Healthcare REIT, Inc.
 Aug 17, 2026 BUY Strong Buy
+1.7% avg upside
16 analysts
$71.00
30.47% Upside
 · ·
SBRA
Sabra Healthcare REIT
 Aug 17, 2026 BUY Buy
-1.8% avg upside
29 analysts
 — · ·
OHI
Omega Healthcare
 Aug 14, 2026 SELL Buy
-5.3% avg upside
30 analysts
$49.00
5.69% Upside
 -0.0% ·
CTRE
CareTrust REIT
 Aug 14, 2026 BUY Strong Buy
-5.6% avg upside
22 analysts
$49.00
25.60% Upside
 +0.0% ·
JAN
Janus Living, Inc. Class A
 Aug 07, 2026 BUY Strong Buy
+2.8% avg upside
11 analysts
$34.00
12.14% Upside
 +0.7% ·
ARE
Alexandria Equities
 Aug 07, 2026 HOLD Buy
+57.2% avg upside
26 analysts
$54.00
16.45% Upside
 -2.8% ·
WELL
Welltower
 Aug 03, 2026 BUY Strong Buy
-19.5% avg upside
33 analysts
$292.00
24.14% Upside
 +1.4% ·
NHI
National Health Investors
 Jun 10, 2026 BUY Buy
+0.4% avg upside
17 analysts
$91.00
25.39% Upside
 +1.5% ·
DOC
Healthpeak Properties
 Apr 14, 2026 BUY Buy
+15.9% avg upside
43 analysts
$20.00
2.80% Downside
 +25.8% ·
MPT
Medical Properties Trust
 Nov 17, 2025 SELL Hold
+190.7% avg upside
24 analysts
$4.50
10.76% Upside
 +14.2% ·
🔒 5 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Farrell Granath — Frequently Asked Questions
How accurate are Farrell Granath's stock ratings?
Based on the calls 13Foresight could measure, about 43% of Farrell's ratings were profitable over a one-year hold, with an average return of +2.6% per rating, or +53.0% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Farrell ranked on 13Foresight?
Farrell Granath is currently ranked #1821 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Farrell cover?
Farrell most recently has ratings on AHR, SBRA, OHI, CTRE, JAN, ARE, WELL, NHI, DOC, MPT. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.